Halozyme Therapeutics Statistics
Total Valuation
HALO has a market cap or net worth of $11.43 billion. The enterprise value is $13.64 billion.
| Market Cap | 11.43B |
| Enterprise Value | 13.64B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HALO has 114.01 million shares outstanding. The number of shares has decreased by -2.62% in one year.
| Current Share Class | 114.01M |
| Shares Outstanding | 114.01M |
| Shares Change (YoY) | -2.62% |
| Shares Change (QoQ) | +1.15% |
| Owned by Insiders (%) | 1.05% |
| Owned by Institutions (%) | 111.59% |
| Float | 112.70M |
Valuation Ratios
The trailing PE ratio is 25.26 and the forward PE ratio is 9.55.
| PE Ratio | 25.26 |
| Forward PE | 9.55 |
| PS Ratio | 6.34 |
| Forward PS | 5.38 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.90 |
| P/OCF Ratio | 12.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.96, with an EV/FCF ratio of 15.39.
| EV / Earnings | 28.09 |
| EV / Sales | 7.57 |
| EV / EBITDA | 11.96 |
| EV / EBIT | 13.35 |
| EV / FCF | 15.39 |
Financial Position
The company has a current ratio of 3.88
| Current Ratio | 3.88 |
| Quick Ratio | 3.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.84 |
| Debt / FCF | 3.70 |
| Interest Coverage | 46.32 |
Financial Efficiency
Return on equity (ROE) is 216.38% and return on invested capital (ROIC) is 29.76%.
| Return on Equity (ROE) | 216.38% |
| Return on Assets (ROA) | 22.42% |
| Return on Invested Capital (ROIC) | 29.76% |
| Return on Capital Employed (ROCE) | 34.08% |
| Weighted Average Cost of Capital (WACC) | 7.25% |
| Revenue Per Employee | $4.26M |
| Profits Per Employee | $1.15M |
| Employee Count | 423 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.72 |
Taxes
In the past 12 months, HALO has paid $169.59 million in taxes.
| Income Tax | 169.59M |
| Effective Tax Rate | 25.89% |
Stock Price Statistics
The stock price has increased by +41.97% in the last 52 weeks. The beta is 0.90, so HALO's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +41.97% |
| 50-Day Moving Average | 114.56 |
| 200-Day Moving Average | 85.43 |
| Relative Strength Index (RSI) | 26.68 |
| Average Volume (20 Days) | 2,362,595 |
Short Selling Information
The latest short interest is 13.65 million, so 11.97% of the outstanding shares have been sold short.
| Short Interest | 13.65M |
| Short Previous Month | 13.65M |
| Short % of Shares Out | 11.97% |
| Short % of Float | 12.11% |
| Short Ratio (days to cover) | 6.19 |
Income Statement
In the last 12 months, HALO had revenue of $1.80 billion and earned $485.42 million in profits. Earnings per share was $3.97.
| Revenue | 1.80B |
| Gross Profit | 1.37B |
| Operating Income | 1.02B |
| Pretax Income | 655.01M |
| Net Income | 485.42M |
| EBITDA | 1.14B |
| EBIT | 1.02B |
| Earnings Per Share (EPS) | $3.97 |
Balance Sheet
The company has $1.07 billion in cash and $3.28 billion in debt, with a net cash position of -$2.20 billion or -$19.34 per share.
| Cash & Cash Equivalents | 1.07B |
| Total Debt | 3.28B |
| Net Cash | -2.20B |
| Net Cash Per Share | -$19.34 |
| Equity (Book Value) | -55.24M |
| Book Value Per Share | -0.48 |
| Working Capital | 1.37B |
Cash Flow
In the last 12 months, operating cash flow was $898.27 million and capital expenditures -$12.39 million, giving a free cash flow of $885.88 million.
| Operating Cash Flow | 898.27M |
| Capital Expenditures | -12.39M |
| Depreciation & Amortization | 118.88M |
| Net Borrowing | 1.28B |
| Free Cash Flow | 885.88M |
| FCF Per Share | $7.77 |
Margins
Gross margin is 76.00%, with operating and profit margins of 56.67% and 26.93%.
| Gross Margin | 76.00% |
| Operating Margin | 56.67% |
| Pretax Margin | 36.34% |
| Profit Margin | 26.93% |
| EBITDA Margin | 63.27% |
| EBIT Margin | 56.67% |
| FCF Margin | 49.15% |
Dividends & Yields
HALO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.62% |
| Shareholder Yield | 2.62% |
| Earnings Yield | 3.96% |
| FCF Yield | 7.75% |
Analyst Forecast
The average price target for HALO is $119.89, which is 19.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $119.89 |
| Price Target Difference | 19.57% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 18.46% |
| EPS Growth Forecast (3Y) | 42.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on December 10, 2003. It was a forward split with a ratio of 4.275:1.
| Last Split Date | Dec 10, 2003 |
| Split Type | Forward |
| Split Ratio | 4.275:1 |
Scores
HALO has an Altman Z-Score of 3.45 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.45 |
| Piotroski F-Score | 6 |